Results 81 to 90 of about 187,783 (355)

Evaluation of Proteinuria [PDF]

open access: yesMayo Clinic Proceedings, 1994
Proteinuria, a common finding on urinalysis, may indicate the presence of a wide variety of medical conditions, some of which are benign and associated with a favorable prognosis (such as orthostatic proteinuria) and others of which have more serious implications (such as glomerular disease or multiple myeloma).
openaire   +2 more sources

Dysproteinemia, proteinuria, and glomerulonephritis [PDF]

open access: yesKidney International, 2006
CASE PRESENTATION A 57-year-old woman was referred for evaluation of new-onset hypertension and proteinuria. The patient had developed lower extremity edema 3 months prior and had been treated with diuretics. Past medical history was significant for microscopic hematuria of many years’ duration thought secondary to nephrolithiasis, longstanding ...
M.A. Swidler   +5 more
openaire   +3 more sources

Outcome of Patients With Lupus Nephritis Treated With an Anti‐CD40 Monoclonal Antibody According to Kidney Biopsy Features

open access: yesArthritis &Rheumatology, EarlyView.
Objective A phase 2 trial tested different doses of the anti‐CD40 monoclonal antibody BI 655064 as an add‐on therapy to the standard of care in patients with class III or IV lupus nephritis (LN) with active disease. A post hoc analysis showed a potential benefit of the higher tested doses (180 and 240 mg) versus a low dose (120 mg) or placebo.
Martina Uzzo   +5 more
wiley   +1 more source

Renal impairment in a rural African antiretroviral programme [PDF]

open access: yes, 2009
Background: There is little knowledge regarding the prevalence and nature of renal impairment in African populations initiating antiretroviral treatment, nor evidence to inform the most cost effective methods of screening for renal impairment.
A Mocroft   +23 more
core   +3 more sources

The tacrolimus concentration‐to‐dose ratio is associated with kidney function in heart transplant recipients

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Heart transplantation (HT) is frequently complicated by chronic kidney disease, of which tacrolimus‐related nephrotoxicity is an important cause. In kidney and liver transplant recipients, fast tacrolimus metabolism (defined as a low concentration‐to‐dose [C0/D] ratio), negatively affects kidney function.
Maaike R. Schagen   +9 more
wiley   +1 more source

Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why?

open access: yes, 2023
The Laryngoscope, Volume 133, Issue 1, Page 2-3, January 2023.
Craig S. Derkay   +9 more
wiley   +1 more source

Baseline proteinuria level is associated with prognosis in idiopathic membranous nephropathy

open access: yesRenal Failure, 2019
Objectives: This study aimed to investigate the unique prognostic, clinical, and renal histopathological characteristics of patients with idiopathic membranous nephropathy (IMN) with different levels of proteinuria.
Xinxin Chen   +8 more
doaj   +1 more source

Antiproteinuric action of amiloride in paediatric patient with corticoresistant nephrotic syndrome

open access: yesNefrología (English Edition), 2021
Introduccion: In nephrotic syndrome, increased podocyturia accompanies pathologic proteinuria. The therapeutic regimen with enalapril, losartan and amiloride could reduce both variables.
Miguel Liern   +3 more
doaj  

Prophylactic inhibition of soluble epoxide hydrolase delays onset of nephritis and ameliorates kidney damage in NZB/W F1 mice [PDF]

open access: yes, 2019
Epoxy-fatty-acids (EpFAs), cytochrome P450 dependent arachidonic acid derivatives, have been suggested to have anti-inflammatory properties, though their effects on autoimmune diseases like systemic lupus erythematosus (SLE) have yet to be investigated ...
Dragun, Duska   +9 more
core   +2 more sources

Efficacy and safety of first‐line sintilimab plus anlotinib versus chemotherapy for metastatic non‐small cell lung cancer: a phase II, open‐label, randomized controlled trial

open access: yesCancer Communications, EarlyView.
Abstract Background The prognosis for non‐small cell lung cancer (NSCLC) patients treated with standard platinum‐based chemotherapy was suboptimal, with safety concerns. Following encouraging results from a preliminary phase I study, this phase II trial investigated the efficacy and safety of first‐line sintilimab and anlotinib in metastatic NSCLC ...
Tianqing Chu   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy